Compare AU
Compare VDGR vs. IXJ
Compare shares and ETFs on the ASX that you can trade on Pearler.
Overview
When it comes to investing in the Australian stock market, Exchange-Traded Funds (ETFs) are a popular choice. Two well-known options in the Australian Securities Exchange (ASX) are the Vanguard Diversified Growth Index ETF (VDGR) and the S&P Global 1200 Healthcare (IXJ). In this comparison, we'll delve into these ETFs across various dimensions to help you make an informed investment decision.
Community Stats
VDGR | IXJ | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 107 | 241 |
Median incremental investment | $1,052.75 | $1,000.00 |
Median investment frequency | Monthly | Monthly |
Median total investment | $3,240.54 | $1,668.00 |
Average age group | > 35 | 26 - 35 |
Key Summary
VDGR | IXJ | |
|---|---|---|
Strategy | VDGR.AX was created on 2017-11-20 by Vanguard. The fund's investment portfolio concentrates primarily on target outcome asset allocation. The Fund seeks to achieve its objective by employing a passive investment strategy that tracks the weighted average return of the various indices of the Underlying Funds in which the Fund invests, in proportion to the SAA for the Fund, before takinginto account fees, expenses and tax | IXJ.AX was created on 2001-11-13 by iShares. The fund's investment portfolio concentrates primarily on health care equity. The Fund aims to provide investors with the performance of an index, before fees and expenses. The index is designed to measure the performance of global biotechnology, healthcare, medical equipment and pharmaceuticals companies and may include large-, mid- or smallcapitalisation stocks |
Top 3 holdings | BHP Group Ltd. (3.01 %) Commonwealth Bank of Australia (2.40 %) CSL Ltd. (1.89 %) | Eli Lilly and Company (8.25 %) UnitedHealth Group Incorporated (5.81 %) Johnson & Johnson (4.72 %) |
Top 3 industries | Other (31.32 %) Financials (13.67 %) Information Technology (9.13 %) | Other (99.98 %) Communication Services (0.02 %) |
Top 3 countries | United States (39.83 %) Australia (38.22 %) Japan (3.61 %) | United States (99.97 %) |
Management fee | 0.27 % | 0.46 % |
Key Summary
VDGR | IXJ | |
|---|---|---|
Issuer | Vanguard | iShares |
Tracking index | 28% S&P/ASX 300 Index - 20.5% MSCI World ex-Australia Index - 12.5% MSCI World ex Australia Hedged to AUD Index - 5% MSCI World ex-Australia Small Cap Index - 34% Other Benchmark | S&P Global 1200 Healthcare Sector Index - AUD |
Asset class | ETF | ETF |
Management fee | 0.27 % | 0.46 % |
Price | $63.54 | $139.00 |
Size | $1.222 million | $1.414 billion |
10Y return | N/A | 126.37 % |
Annual distribution yield (5Y) | 5.01 % | 1.26 % |
Market | ASX | ASX |
First listed date | 22/11/2017 | 11/03/2009 |
Purchase fee | $6.50 | $6.50 |
Community Stats
VDGR | IXJ | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 107 | 241 |
Median incremental investment | $1,052.75 | $1,000.00 |
Median investment frequency | Monthly | Monthly |
Median total investment | $3,240.54 | $1,668.00 |
Average age group | > 35 | 26 - 35 |
Pros and Cons
VDGR | IXJ | |
|---|---|---|
Pros |
|
|
Cons |
|
|
VDGR | IXJ |
|---|---|
Higher exposure to AU market | Lower exposure to AU market |
Lower exposure to US market | Higher exposure to US market |
Lower management fee | Higher management fee |
Lower price growth | Higher price growth |
Higher distribution yield | Lower distribution yield |